Original Research

Accepted on 24 Dec 2024

Analysis of Nanomedicine Applications for Inflammatory Bowel Disease: Structural and Temporal Dynamics, Research Hotspots, and Emerging Trends

in Gastrointestinal and Hepatic Pharmacology

Hong-Yu Jiang
Bo Shao
Hong-da Wang
Wen-Qi Zhao
Shao-hua Ren
Yi-ni Xu
Tong Liu
Cheng-lu Sun
Yi-yi Xiao
Yi-cheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1523052

Original Research

Accepted on 20 Dec 2024

Polydatin protects against DSS-induced ulcerative colitis via Nrf2/Slc7a11/Gpx4-dependent inhibition of ferroptosis signalling activation

in Gastrointestinal and Hepatic Pharmacology

Shimin Zheng
Jianbin Yin
Bingbing Wang
Qiujuan Ye
Jialuo Huang
Junfeng Wu
Xinzhi Liang
Hui Yue
Ting Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1513020

Original Research

Published on 19 Dec 2024

A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database

in Gastrointestinal and Hepatic Pharmacology

Ya-Jun Zhang
Dan-Dan Duan
Qian-Yu Tian
Cai-E. Wang
Shu-Xun Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1524903

182 views

Review

Published on 19 Dec 2024

Apigenin as an emerging hepatoprotective agent: current status and future perspectives

in Gastrointestinal and Hepatic Pharmacology

Cheng Wang
Xiaoli Feng
Wen Li
Li Chen
Xinming Wang
Yimiao Lan
Rong Tang
Ting Jiang
Lingli Zheng
Gang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508060

166 views

Original Research

Accepted on 18 Dec 2024

Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: a multicenter propensity score matching analysis

in Gastrointestinal and Hepatic Pharmacology

Zhonghua Zhao
Xiongying Jiang
Shiping Wen
Yanzhang Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499269

Original Research

Published on 18 Dec 2024

Polysaccharides derived from golden mushroom (Cantharellus cibarius Fr.) modulate gut microbiota and enhance intestinal barrier function to ameliorate dextran sulfate sodium-induced colitis in mice

in Gastrointestinal and Hepatic Pharmacology

Yamina Alioui
Hidayat Ullah
Sharafat Ali
Mujeeb Ur Rahman
Maroua Elkharti
Nabeel Ahmed Farooqui
Ata Ur Rehman
Muhammad Ilyas
Duaa M. Alsholi
Nimra Zafar Siddiqi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498625

276 views

Review

Published on 18 Dec 2024

FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects

in Gastrointestinal and Hepatic Pharmacology

Wanqing Wang
Xue Liu
Lingling Zhao
Kaipeng Jiang
Ziyi Yu
Ruihan Yang
Wenshuo Zhou
Jiuwei Cui
Tingting Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505027

179 views

Original Research

Published on 17 Dec 2024

Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway

in Gastrointestinal and Hepatic Pharmacology

Hang Chen
Minshan Huang
Dan Zhang
Hui Wang
Da Wang
Mengwei Li
Xianmei Wang
Rui Zhu
Jianjun Liu
Lanqing Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477212

220 views

Review

Accepted on 16 Dec 2024

Functions of METTL1/WDR4 and QKI as m7G modification -related enzymes in digestive diseases

in Gastrointestinal and Hepatic Pharmacology

Wenyan Zhou
Yan Yi
Wenyu Cao
Xiaolin Zhong
Ling Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491763

Original Research

Accepted on 16 Dec 2024

Analysis of the Risk of Oncological Adverse Events Associated with Infliximab in Combination with Azathioprine Compared to Monotherapy: Insights from the FAERS Database

in Gastrointestinal and Hepatic Pharmacology

Qian Qiao
Ying ying Mi
Ya Zheng
Min Liu
Ya nan Gong
Jia hui Liu
Wen yue Rui
Yu mei Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507196

Original Research

Accepted on 16 Dec 2024

Current research status and trends of potassium-competitive acid blockers in the treatment of acid-related diseases: a bibliometric analysis

in Gastrointestinal and Hepatic Pharmacology

Baoqiang Zhu
Long Chen
Xue Tao
Hong Zheng
Xia Li
Qingfang Wu
Enwu Long
Haixia Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477633

Original Research

Accepted on 13 Dec 2024

Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter

in Gastrointestinal and Hepatic Pharmacology

Dongdong Zhou
Huiwen Yan
Xiaoli Liu
Peng Wang
Tingting Jiang
Zhiyun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449603

Original Research

Accepted on 13 Dec 2024

Elucidation of the mechanism of berberine against gastric mucosa injury in a rat model with chronic atrophic gastritis based on a combined strategy of multi-omics and molecular biology

in Gastrointestinal and Hepatic Pharmacology

Lisheng Chen
Xin Wang
Jianyu Li
Lijuan Zhang
Wenbin Wu
Shizhang Wei
Wenjun Zou
Yanling Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499753

Original Research

Accepted on 13 Dec 2024

Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database

in Gastrointestinal and Hepatic Pharmacology

Bojing Wang
Shu Huang
Shiqi Li
Yaqi Deng
Ziyan Li
Yizhou Wang
Xiaomin Shi
Wei Zhang
Lei Shi
Xiaohong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502791

Editorial

Published on 13 Dec 2024

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

in Gastrointestinal and Hepatic Pharmacology

Isis Trujillo-Gonzalez
Paul G. Thomes
Isin Tuna Sakallioglu
Kusum K. Kharbanda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1529088

194 views

Systematic Review

Accepted on 10 Dec 2024

Systematic Review and Bayesian Network Meta-Analysis: Comparative Efficacy and Safety of Six Commonly Used Biologic Therapies for Moderate-to-Severe Crohn's Disease

in Gastrointestinal and Hepatic Pharmacology

Haohang Su
Shengwei Xiao
Tianrong Xun
Xixiao Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475222

Navigation group

Articles

Analysis of Nanomedicine Applications for Inflammatory Bowel Disease: Structural and Temporal Dynamics, Research Hotspots, and Emerging Trends

Polydatin protects against DSS-induced ulcerative colitis via Nrf2/Slc7a11/Gpx4-dependent inhibition of ferroptosis signalling activation

A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database

Apigenin as an emerging hepatoprotective agent: current status and future perspectives

Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: a multicenter propensity score matching analysis

Polysaccharides derived from golden mushroom (Cantharellus cibarius Fr.) modulate gut microbiota and enhance intestinal barrier function to ameliorate dextran sulfate sodium-induced colitis in mice

FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects

Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway

Functions of METTL1/WDR4 and QKI as m7G modification -related enzymes in digestive diseases

Analysis of the Risk of Oncological Adverse Events Associated with Infliximab in Combination with Azathioprine Compared to Monotherapy: Insights from the FAERS Database

Current research status and trends of potassium-competitive acid blockers in the treatment of acid-related diseases: a bibliometric analysis

Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter

Elucidation of the mechanism of berberine against gastric mucosa injury in a rat model with chronic atrophic gastritis based on a combined strategy of multi-omics and molecular biology

Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

Systematic Review and Bayesian Network Meta-Analysis: Comparative Efficacy and Safety of Six Commonly Used Biologic Therapies for Moderate-to-Severe Crohn's Disease